Prices for the top 25 brand-name Medicare Part D drugs have increased by an average of 98% since entering the market, ...

Hims & Hers Health (HIMS) stock gained after Citi upgraded the company, while agilon health (AGL) stock slipped after its downgrade. Read more here.

Hims & Hers reported impressive third-quarter results in November, with earnings of 32 cents per share, far exceeding analyst ...

Hims offers convenient and affordable access to treatments and products tailored for men's health needs. But how much does it ...

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

OpenAI CEO Sam Altman and Meta both announced $1 million donations, and Amazon and Apple CEO Tim Cook have also reportedly ...

Eli Lilly has been riding the weight-loss drug wave. The company's weight-loss drugs have been shown to be more effective than rival Ozempic. The stock currently trades at an attractive valuation.

consuming over a bottle of whiskey nightly and experimenting with drugs like cocaine, heroin, ecstasy, LSD, speed, and cannabis. Regarding his bond with Katie Price, he notes: "I had always got on ...

We recently published an article titled Market Slump Drags Down Share Prices of ... the impact on Hims & Hers Health, which had been offering compounded versions of such drugs.

and erectile dysfunction. Right off the bat, I see a lot of overlap between the Hims & Hers platform and Amazon's bolstered offerings through its online pharmacy. Below, I'll dig into what makes ...

and erectile dysfunction. Right off the bat, I see a lot of overlap between the Hims & Hers platform and Amazon's bolstered ...

HIMS & HERS HEALTH INC (HIMS) is a mid-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 77% based on the firm’s underlying fundamentals and the stock’s ...